tirzepatide 10 ml vial 10mg UK 2026 like peptide Tirzepatide Flex-Dose 3 mL Injectable

If shedding coincides with the most aggressive dose escalation or the steepest weight-loss phase, your prescriber may consider pacing changes while keeping your broader goals on track

These results are sustained long-term too, with 10.2% average weight loss maintained at four years when consistently using the medication

Recent labs are strongly recommended (but not required) prior to initiation of most weight loss medications

Wegovy offers higher doses of semaglutide (up to 2.4 mg weekly) compared to Ozempic (12 mg weekly), which may explain the difference in weight loss outcomes

Efficacy and Weight-Loss Results FDA-approved semaglutide has garnered significant recognition for its ability to: Promote Steady Weight Reduction In higher doses (e.g., as Wegovy), it has demonstrated substantial weight loss in clinical settings